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Neural Stem Cells (NSCs) are a distinct group of cells present in the embryonic and adult mammalian central
nervous system (CNS) that are able to differentiate into neurons, astrocytes and oligodendrocytes. As NSC
proliferation declines with age, factors that regulate this process need to be defined. To search for NSC regulatory
factors, we performed a quantitative shotgun proteomics study that revealed that members of the High Mobility
Group B (HMGB) family are highly expressed in NSCs. Using a neurosphere assay, we report the differential
expression of HMGB 1, 2, 3, and 4 mRNAs in proliferating NSCs isolated from various time points during embryonic
development, as well as the dynamic expression of HMGB1 and B2 mRNAs and proteins in differentiating
embryonic NSCs. Expression of HMGB2 underwent the most dramatic changes during the developmental ages
examined; as a result, we assessed its role in NSC proliferation and differentiation. We report the predominance of
small diameter HMGB2-/- neurospheres in comparison to wild-type, which correlated with increased proliferation in
these smaller HMGB2-/- neurospheres. Our data suggest that HMGB2 plays a regulatory role in NSC cell proliferation
and maintenance pathways.
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During embryonic development, neuroepithelial cells in
the cerebral cortex display characteristics of radial glial
cells [1]. These radial glial cells undergo asymmetric divi-
sions and generate neurons and oligodendrocytes. As de-
velopment progresses and the cortical mantle becomes
thicker, the radial glial cells also express astrocytic markers
and intermediate filament proteins (nestin, vimentin, and
glial fibrillary acidic protein-GFAP). Some of the radial
glial cells remain as NSCs during early postnatal develop-
ment, finally giving rise to the B cells which function as
NSCs in the adult mammalian brain [1]. Neural Stem
Cells (NSCs) give rise to progenitor cells that differentiate* Correspondence: stella@pharm.stonybrook.edu
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reproduction in any medium, provided the orinto the three principal cell types of the CNS: neurons, as-
trocytes and oligodendrocytes [2,3].
Studies of these putative embryonic and adult NSCs
have defined some of the mitogens that regulate NSC pro-
liferation [4-8], but the precise molecular mechanisms
underlying stem cell maintenance and self-renewal remain
incompletely understood. As the animals age, the total
number of NSCs and proliferating neural stem/progenitor
cells (NSPCs) declines [9]. A contributor to the decrease
in NSC cell numbers in the subventricular zone (SVZ) is
the progressive increase in p16Ink4a expression [10]. To
gain insight into the molecular mechanisms regulating
NSC proliferation, studies have focused on regulators of
p16Ink4a expression, such as high mobility group protein
A2 (HMGA2) [11], which is a member of the HMG super-
family of non-histone proteins found in the nuclei of
mammalian cells that bind to nucleosomes and the minor
groove of DNA in a sequence-independent manner
[12-14]. HMGA2 expression is spatially and temporally
specified in CNS tissue; it remains high in the embryonical Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the CNS during the early post-natal period (P0), but de-
creases throughout post-natal development and adult-
hood, becoming undetectable in old age (P600) [11]. The
microRNA Let7b, which negatively regulates HMGA2
expression [15], is temporally regulated in NSCs [11]. The
Let7b-HMGA2 axis regulates p16Ink4a expression, which
in turn controls NSC proliferation and self-renewal [16].
The HMG superfamily is composed of three subfamilies:
HMG-A, HMG-B, and HMG-N [12,17,18], which act as
modulators of transcription, replication, recombination,
and DNA repair. Following up on the role of HMGA2
in regulating p16Ink4a expression and NSC proliferation,
additional studies have reported that the HMGA family of
proteins maintain NSC/NPC chromatin in the open state
during early development [19]. Moreover, HMGA pro-
teins were identified by iTRAQ proteomic analysis as
being expressed during oligodendrocyte precursor cell
(OPC) differentiation [20], and transcriptional profiling
studies have found that NSCs express HMGB1, HMGB2
and HMGB3 mRNA [21]. A recent study in zebrafish
reported that HMGB1 is critical for early brain develop-
ment, since morpholino-knockdown of HMGB1 expre-
ssion created forebrain defects and ablation of the
catecholamine network [22]. HMGB2 is expressed 17-
fold higher in the SVZ stem cell niche than in the olfac-
tory bulb (OB) [23], suggesting a specific role for HMGB2
in SVZ NSC proliferation.
We employed here a shotgun proteomic analysis to
identify factors involved in NSC proliferation; the analysis
uncovered that members of the HMGB family are variably
expressed in mouse NSCs. The proteomics findings were
confirmed by real-time PCR and immunoblot analyses
during NSC proliferation and differentiation. Our data
specifically identify the HMGB1 and B2 proteins as factors
expressed and modulated in proliferating and differentiat-




Experiments were performed within the Stony Brook
University (SBU) guidelines regarding the ethical use of
animals and were approved by the SBU Institutional
Animal Care and Use Committee. The mouse strains
used were C57BL/6 (wild-type, wt), HMGB2-/- in the
C57BL/6 background and nestin-GFP in the C57BL/6
background.
Neural stem cell (NSC) isolation, growth, and
differentiation
Pregnant mice were euthanized under deep anesthesia
at E12.5. Embryos were placed in ice-cold NSC proli-
feration medium composed of neurobasal mediumcontaining Neurocult proliferation supplement (Stem
Cell Technologies) and antibiotic/antimycotic (Gibco).
Embryonic mouse brains were dissected and dissociated by
trituration. Cells were centrifuged at 800 rpm for 5 minutes,
supernatant removed and the pellet resuspended in 10 mL
of NSC proliferation media. Viable cells were counted by
trypan blue staining. Primary neurospheres were grown in
a 5% CO2 chamber at 37°C by seeding 8×10
6 viable cells
at a cell concentration of 2×105/mL in NSC proliferation
media containing 20 ng/mL of recombinant human epi-
dermal growth factor (rhEGF, Sigma).
Primary neurospheres were passaged after 7 days in vitro
using the Neurocult Chemical Dissociation Kit (Stem Cell
Technologies) according to manufacturer’s protocol.
Dissociated NSCs were passed through a 40 μm filter
(BD Falcon) to remove debris and trypan blue used to
determine the number of viable NSCs. 2×106 NSCs
were re-plated in vented T-75 flasks (BD Falcon) at a
cell concentration of 5×104 cells/mL in NSC prolifera-
tion media containing 20 ng/mL rhEGF. NSCs from
each passage were re-plated at the same density (5×104
cells/mL) and rhEGF (20 ng/mL) concentration in NSC
proliferation media.
All NSC differentiation assays were performed on
early passage NSCs (1 and 2). Neurospheres in passages
1 and 2 were dissociated as above. Glass coverslips were
coated with 100 μg/mL poly-D-Lysine (Sigma) and 20
μg/mL Laminin (Sigma) in PBS for 3-4 hours at 37°C.
After laminin coating, dissociated NSCs were plated at
5×105 cells/well in 12-well plates in Neurocult differen-
tiation media (Stem Cell Technologies) without rhEGF
supplementation. Differentiation media changes were
done once per day per well until the NSCs were lysed
for collection of RNA or protein. For evaluation of dif-
ferentiation by immunofluorescence, NSCs were fixed
in 4% PFA, washed in PBS, blocked in 5% goat serum
and stained overnight at 4 degrees in 0.3% BSA/0.2%
TritonX/PBS with mouse anti-βIII tubulin (MAB1637,
Millipore, 1:500) to identify neurons, with mouse anti-
GFAP (Sigma, 1:1,000) to identify astrocytes, and anti-CNP
(Sigma C5922 1:100) to identify oligodendrocytes. Species-
specific secondary antibodies (Invitrogen, 1:10,000) and
DAPI (Invitrogen, 1:2,000) in 0.3% BSA/0.2% TritonX/
PBS were used for secondary staining. Confocal imaging
of differentiated NSCs was performed using a Zeiss 510
Meta confocal microscope.
To assess NSC proliferation, neurosphere cultures were
pulse-labeled with bromodeoxyuridine (BrdU, 0.5 uM),
which labels cells during S-phase. The spheres were trans-
ferred to PDL-coverslips, fixed and processed for BrdU
(rat anti-BrdU antibody, Serotec, 1:300) immunofluores-
cence. To quantify cell death in the neurospheres, the cul-
tures were fixed and labeled with anti-activated caspase 3
(Sigma C8487, 1:500). The cells were counterstained with
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ages of BrdU- or caspase 3-positive cells were counted.
Shotgun proteomic analysis
NSC Lysis
NSC lysis buffer was made using 8 M urea (Sigma) in
50 mM NH4HCO3 (pH7.5) (Sigma) using HPLC-grade
water (Thermo Scientific). 1 mg of RapiGest SF (Waters)
was reconstituted with 50 mM NH4HCO3 to make 2%
RapiGest (w/v). 5× Invitrosol LC/MS protein solubilizer
was obtained from Invitrogen. Complete Mini, EDTA-free
protease inhibitor cocktail was purchased from Roche. To
make mass-spectrometry compatible NSC lysis buffer,
protease inhibitor (1×), Invitrosol (1×), urea (4 M final)
and RapiGestSF (0.1% w/v final) were added to NH4HCO3
(50 mM final). NSCs were lysed with 100 μL of lysis buffer
on ice and the DNA sheared with a 25-gauge needle at-
tached to a 1 mL syringe (BD). A different needle and
syringe were used for each biological NSC sample and all
technical replicates. Lysates were incubated in a foam pad
attached to a vortex for 30 min at 4° to facilitate the
solubilization of proteins and centrifuged at 13,200 rpm at
4° for 30 minutes, and the supernatants transferred to
new, ice-cooled, non-stick microcentrifuge tubes and left
on ice. Insoluble proteins remaining in the NSC debris
pellet were solubilized by adding 100 μL of NSC lysis
buffer containing 6 M urea (final concentration). Tubes
containing insoluble protein pellets and additional lysis
buffer were vortexed at 4° for 30 minutes, centrifuged at
13,200 rpm at 4° for 30 minutes, and the supernatants
pooled with their respective soluble protein supernatants
on ice. For fractionated NSC lysates, NSCs were lysed and
fractionated according to manufacturer protocol using the
ProteoExtract native membrane protein extraction kit
(Calbiochem). Protein determination was preformed using
the EZQ Protein Quantitation Kit (Invitrogen).
Digestion and preparation of whole NSC and soluble
fraction NSC protein lysates
10 μg protein from each sample was precipitated using
methanol-chloroform precipitation. Protein pellets were
resuspended in 1× Invitrosol, heated to 60° for 5 minutes,
cooled to room temperature, dissolved in acetonitrile
(Sigma) and sonicated for 2 hours in a 37° water bath.
Proteins were digested with Trypsin (Sigma, 1:100) at 37°
overnight, and quenched with 90% Formic acid (10% final)
the following day. Peptide pellets were dried down by
speed vacuum to almost dry and resuspended in buffer A
(5% acetonitrile/95% water/0.1% Formic Acid).
Digestion and preparation of membrane NSC protein lysates
10 μg of membrane protein was methanol-chloroform pre-
cipitated, resuspended in Rapigest, reduced using TCEP
(2-Carboxylethyl-Phosphine), alkylated with iodoacetamide(IAM), and digested with trypsin (1:50) overnight. RapiGest
was hydrolyzed by adding 90% Formic Acid (10% final)
and incubated in a shaking 37° water bath for 4 hours.
Samples were dried down by speed vacuum and resus-
pended in buffer A.
LC Mass Spectrometry analysis: NSC peptides were
analyzed using a LTQ XL linear ion trap mass spectro-
meter (Finnigan, Thermo Scientific). MS analysis spectra
were extracted from the RAW file with ReAdW.exe
(http://sourceforge.net/projects/sashimi). The resulting
mzXML file contains the data for all MS/MS spectra
and can be read by the subsequent analysis software
(Additional file 1). The MS analysis data was searched
with Inspect [24] against a database containing a mouse
database (IPI ver. 3.43 containing 54215 entries) with
added E.coli and common contaminant proteins (in total
4605 proteins) in addition to a shuffled database of the
aforementioned proteins. Only peptides with at least a
p value of 0.01 were analyzed further.
qRT-PCR and immunoblots
Mouse NSCs were isolated from the forebrain of
NestinGFP mice. Samples were cut in the ventral-dorsal
plane immediately caudal to the telencephalon to ensure
the separation of the telencephalon from the developing
mid/hindbrain and spinal cord. The developmental
characteristics of each embryo were verified using the
Theiler Atlas of Mouse Development [25].
Total RNA was isolated from proliferating and diffe-
rentiating NSCs using the RNeasy RNA Isolation Kit
(Qiagen) and levels were quantified. Prior to reverse
transcription, RNA samples were treated with DNAse
(Invitrogen). 750 ng of total RNA (DNAse-treated) was
reverse transcribed using the Superscript III First-
Strand Synthesis System for RT-PCR (Invitrogen). NSC
cDNA was used to conduct quantitative real time RT-
PCR (qRT-PCR) using the SYBRGreen PCR kit (Qiagen)
with gene specific primers for HMGB1, B2, B3, and B4.
Reactions were read in a 7300 Real Time PCR System
(Applied Biosystems). β-actin primers served as a
normalization control. Primer Sequences were:
HMGB1(L) 50ACAGAGCGGAGAGAGTGAGG 30 and
HMGB1(R) 50TTTGCCTCTCGGCTTTTTAG 30;
HMGB2(L) 50 TGTCCTCGTACGCCTTCTTC 30 and
HMGB2(R) 50 CCTCCTCATCTTCTGGTTCG 30;
HMGB3(L) 50GCGAACAATACAGGTACGACTC 30
and HMGB3(R) 50 CTTGGCACCATCAAACTTCC 30;
HMGB4(L) 50 CGGGACCACTATGCTATGCT 30 and
HMGB4(R) 50 CTTCCTGCCTTGACATTGG 30.
Cycling conditions for HMGB1 were: 95° for 15 min,
94° for 15 sec (melting), 53.2° for 30 sec (annealing), 72°
for 30 sec (extension), repeat for 40 cycles, 4° hold until
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HMGB2 and HMGB3, and to 50.3° for HMGB4. Fold
change in gene expression was calculated using the com-
parative CT method [26]. All qRT-PCR reactions were
run in quadruplicate (4 technical replicates per sample).
At least three different biological samples of NSCs at each
time point in development were used for each experiment
(n=3 experiments).
For quantitative westerns, proliferating and differentiat-
ing NSCs were lysed and protein determination was done
by DC assay (Biorad). Equal amounts of protein were
loaded into 12 or 15% Tris Glycine SDS-PAGE, transferred
to PVDF, blocked with 4% BSA/PBS, and incubated over-
night at 4° with primary antibodies: Rabbit anti-HMGB1
(Abcam, 1:1000), Mouse anti-HMGB2 (Abcam, 1:200),
Rabbit anti-HMGB3 (Epitomics, 1:2000), and Rabbit anti-
HMGB4 (Abcam, 1:250). Mouse anti-α-tubulin (Sigma,
1:2000) was used as a loading control. Membranes were
washed in 0.2% PBST and incubated with either Alexa goat
anti-Mouse 680 (Invitrogen) and/or IR DYE Donkey anti-
Rabbit 800 (Jackson) at 1:10,000. Membranes were ana-
lyzed using a LICOR Odyssey Scanner with 700 and 800
nm laser excitation.
SVZ tissue was microdissected from 300 μm-thick cor-
onal brain sections and subjected to protein extraction
using lysis buffer (50 mM Tris-HCl, pH7.5, 1 mM EDTA,
1 mM EGTA, 1 mM sodium orthovanadate, 50 mM so-
dium fluoride, 0.1% 2-mercaptoethanol, 1% triton X-100,
plus proteases inhibitor cocktail; SIGMA). Protein samples
(10-40 μg) were separated on 10% SDS-PAGE and trans-
ferred to PVDF membranes (Millipore, Bedford MA). Pri-
mary antibodies from Santa Cruz Biotechnologies (Caramillo
CA) were used at 1 μg/ml. Antibodies were used in combin-
ation with a secondary horseradish peroxidase-conjugate
(Jackson Immunoresearch).
E15.5 embryos were used for immunohistochemical
(IHC) analysis of HMGB2 expression. Brains were col-
lected in 4% paraformaldehyde, cryopreserved in 30%
sucrose solution overnight, and used to prepare 30 μm
sagittal sections which were blocked and then stained
with rabbit anti-HMGB2 (Proteintech, 1:250) in 0.3%
BSA/0.2% TritonX/PBS solution overnight at 4°C. The
sections were washed with PBS and stained with the
highly cross-absorbed secondary antibody anti-rabbit
rhodamine red X (Jackson 1:500) in 0.3% BSA/0.2%
Triton-X/PBS solution at room temperature for 1 hour.
Sections were washed extensively with PBS, mounted
on Superfrost plus micro slides (VWR), covered with
DAPI Fluoromount G mounting media (Southern
Biotech) and a coverslip (Fisher). A Zeiss LSM 510
confocal system with an Axiovert 200 M inverted
microscope was used to obtain 63× Z-stack images of
the entire thickness of sagittal brain sections containing
the VZ/SVZ.Statistics
Comparisons were conducted using one-tailed unpaired
t tests except for the NSC differentiation qRT-PCR com-
parisons which were conducted using two-tailed paired
t tests. Statistical significance cut-off for all comparisons
was p≤0.05.
Results
HMG subfamily B (HMGB) mRNAs and proteins in NSCs
A neurosphere formation assay was used to grow NSCs
isolated from the brains of embryonic E12.5 C57BL/6
mice [4-6]. The neurospheres expressed the NSC marker
CD133 (Figure 1A-D). They also expressed glial fibrillary
acid protein (GFAP) [27,28] and were highly proliferative,
capable of extensive self-renewal and multipotent diffe-
rentiation, generating astrocytes (GFAP+), neurons (βIII
tubulin+) and oligodendrocytes (CNP+) when plated on
laminin and poly-D-lysine (Figure 1E,F). We subjected
the neurospheres after their 2nd (P2) and 8th (P8) pas-
sage to shotgun proteomics [29]. Using the global pro-
filing approach, we identified 383 proteins expressed in
soluble, membrane, and whole cell lysates (Additional
file 1: Figure S1). The analyses identified several NSC
protein markers including GFAP, nestin, vimentin, and
brain lipid binding protein (BLBP), as well as several
hundred proteins that have not previously been
reported in NSCs.
A heat map of the 20 most abundant NSCs proteins
identified in the MS analysis are shown in Figure 1G.
Nuclear proteins including Matrin3, HMGB1 and
HMGB2 and Myristoylated Alanine-Rich C kinase Sub-
strate (MARCKS) were detected. MARCKS is a protein
kinase C substrate involved in regulation of actin fila-
ment crosslinking [30], which plays a role in embryonic
radial glial proliferation and positioning during mouse
cortical development [31]. In addition, we identified
MARCKS-like protein (MLP), a substrate for protein
kinase C; Chromobox1 (Cb×1), the mammalian homo-
log of Drosophila heterochromatin protein HP1-β that
regulates NSC proliferation and plays a role in mouse
cortical development [32]; and Chromobox3 (Cb×3)
(mammalian HP1-γ). Our analysis also revealed numer-
ous arginine-serine-rich RNA splicing factors (Sfrs1,
Sfrs3, Sfrs4, Sfrs7, Sfrs9, and Sfrs10) and RNA-binding
proteins (Fus and Tardbp), suggesting a prominent role
for RNA function and metabolism components in pro-
liferating embryonic radial glia / NSCs.
Several proteins identified by proteomic analysis were
chosen for validation and confirmed by western blot
analysis including HMGB1 and 2, Hp1 gamma, Matrin3,
and TARDBP (Figure 1H). To verify the expression of
HMGB1 and HMGB2 in proliferating NSCs and explore
whether the remaining HMGB family members, HMGB3
and HMGB4, are also expressed, we used RT-PCR.
Figure 1 Shotgun proteomics screen identifies proteins in proliferating E12.5 NSCs including HMGB chromatin proteins. (A-D)
Neurospheres containing proliferating E12.5 NSCs express stem cell markers. (E-F) NSCs are multipotent and differentiate into βIII tubulin+
neurons, GFAP+ astrocytes, and CNP+ oligodendrocytes. (G) Heat map of protein expression of 20 prominent proteins in proliferating E12.5 NSCs
following passage 2 (P2) and passage 8 (P8) with high (red, >30 spectral counts), medium (yellow, 10-30 spectral counts) and low (white, 1-10
counts) levels of expression. #1 and #2 spectra refer to biological replicates, and the heat map is split into membrane fraction (M), total cell lysate
(T) and soluble/supernatant (S). (H) Immunoblot validation of E12.5 proliferating NSC for proteins identified by the proteomics screen, including
Matrin3, TAR DNA binding protein (TARDBP/TDP43), HP1 gamma, and HMGB1 and B2. 30 μg of total protein were loaded on the gel. (I) RT-PCR
analysis of HMGB1, 2, 3, and 4 mRNA expressions in proliferating E12.5 NSCs. (J) Cellular spatial classification of the proteins identified by
the screen.
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E12.5 NSCs (Figure 1I). All primers spanned exon-
intron boundaries (except B4 which is an intron-less
gene) and the size of all RT-PCR reaction amplification
products were consistent with amplicons of the indivi-
dual HMGB cDNAs. The proteins identified from the
proteomics screen were clustered based on their pre-
dicted cellular localization (Figure 1J).
HMGB2 is expressed in proliferating and differentiating
NSCs
To further examine HMGB2 expression, we used NSCs
isolated from the forebrain of NestinGFP (Figure 2)
transgenic mice [33] at different time points during
embryonic neural development. The presence of the
transgene allowed for better visualization and accurate
dissection of the relevant forebrain structures. qRT-PCR
and quantitative western blots were employed to assess
changes in HMGB2 mRNA and protein expression inproliferating and differentiating NSCs. We used Nestin
GFP+ neurospheres isolated between E12 and E17, a highly
dynamic time period in neural development that is associ-
ated with NSC proliferation and differentiation. NSC pro-
liferation takes place in the medial and lateral ganglionic
eminences (MGE and LGE), and NSC differentiation is
evident during cortical neurogenesis. HMGB2 mRNA ex-
pression was 11.7 fold higher in proliferating NSCs at E12
than at E15.5 (Figure 2A), following a pattern similar to
that of HMGA2 mRNA expression between E14.5 and P0
[11]. In differentiating NSCs, changes in HMGB mRNA
expression in the differentiating spheres were calculated
relative to proliferating NSCs at each developmental time
point, revealing that B2 mRNA expression was decreased
by approximately 10-fold throughout the period examined
(Figure 2B). To assess HMGB protein expression dynam-
ics in proliferating and differentiating NSCs, quantitative
western blots were performed. HMGB2 protein expres-
sion remained constant in proliferating NSCs isolated
Figure 2 Proliferating and differentiating NestinGFP+ NSCs isolated from E12-E15.5 embryonic forebrains differentially express
HMGB2. (A) qRT-PCR analysis of HMGB2 mRNA expression in proliferating forebrain NSCs isolated at different time points during neural
development. (B) qRT-PCR analysis of HMGB2 mRNA expression in differentiating forebrain NSCs isolated at E12, E14.5, and E15.5 and compared
to age-matched proliferating NSCs. Note, in differentiating NSC analysis proliferating NSCs were set to 1. (C) HMGB2 protein is expressed in
proliferating E12-E17.5 NSCs and is differentially expressed in differentiating E12 NSCs. Quantitative western blots of HMGB2 in proliferating NSCs
from embryonic day E12 to E17.5. (D) Quantitative western blot of HMGB2 in differentiating NSCs at 24 and 48 hours after initiation of
differentiation. All values are mean+/- SEM, *p≤0.05, **p≤0.005. (E) In vivo expression pattern of HMGB2 at E15.5 in the VZ/SVZ and cortical plate.
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ating NSCs (Figure 2D). To assess corresponding HMGB2
expression in vivo, we sectioned and stained E15.5 WT
brains for the presence and localization of HMGB2. The
protein was found to be concentrated in the ventricular
zone (VZ) and SVZ as well as in the marginal zone and
the developing cortical plate [34] (Figure 2E). The expres-
sion of mRNA and protein for other members of the
HMGB family was found to vary in proliferating and
differentiating NSCs (Figure 3). HMGB1 mRNA expres-
sion was 5.9-fold higher in proliferating NSCs at E12 thanat E15.5. HMGB3 mRNA expression was 9.6-fold and
21.3-fold higher in proliferating E12 and E14.5 NSCs. For
HMGB4 mRNA expression, the changes were very small
in proliferating NSCs, arguing against a role for HMGB4
in regulating NSC proliferation (Figure 3A). In differenti-
ating NSCs, HMGB1 mRNA expression decreased at all
time points assessed by approximately 5-fold. HMGB3
mRNA expression decreased 10-fold in differentiating E12
NSCs, but did not change significantly in differentiating
E14.5 and E15.5 NSCs. HMGB4 mRNA expression was
unchanged in differentiating NSCs at E12 and E14.5, but
Figure 3 Proliferating and differentiating NestinGFP+ NSCs isolated from E12-E15.5 embryonic forebrains differentially express HMGB
family members. (A) qRT-PCR analysis of HMGB1, HMGB3, and HMGB4 mRNA expression in proliferating NSCs isolated at different time points
during neural development. (B) qRT-PCR analysis of HMGB1, HMGB3, and HMGB4 mRNA expression in differentiating forebrain NSCs isolated at E12,
E14.5, and E15.5 and compared to age-matched proliferating NSCs. Note, in differentiating NSC analysis proliferating NSCs were set to 1. (C) HMGB1, 3,
and 4 proteins are expressed in proliferating E12-E17.5 NSCs, and B1 and B2 proteins are differentially expressed in differentiating E12 NSCs.
Quantitative immunoblots of HMGB1, HMGB3, and HMGB4 in proliferating NSCs from embryonic day E12 to E17.5. (D) Quantitative western blot of
HMGB1 in differentiating NSCs at 24 and 48 hours after initiation of differentiation. All error bars are mean+/- SEM, *p≤0.05, **p≤0.005.
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quantitative immunoblots (Figure 3C), HMGB1 protein
expression remained constant in proliferating NSCs iso-
lated from E12.5 to E17.5. Low HMGB3 protein expres-
sion was detected in proliferating E12 NSCs, sharply
increased at E14.5, and remained high in proliferating
NSCs between E14.5 and E17.5. HMGB4 protein expre-
ssion was not detectable in E12 NSCs, but was present
and stable between E14.5-E17.5 in proliferating NSCs. In
differentiating NSCs, a decrease in HMGB1 protein levels
was evident (Figure 3D). The in vivo spatial expressionprofiles of HMGB1, HMGB3 and HMGB4 have been
documented before and are available in the Allen Brain
Atlas searchable database (http://developingmouse.brain-
map.org/).
HMGB2-/- SVZ neurospheres isolated from embryonic mice
are smaller than HMGB2+/+ SVZ neurospheres in culture
Our data indicated dynamic expression of HMGBs in em-
bryonic NSCs and the most dramatic changes in HMGB2
during proliferation and differentiation. We thus explored
the proliferation and differentiation properties of NSCs in
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have reduced fertility tied to defects in spermatogenesis
[35] as well as perturbations in chondrocyte development
[36]. Using the neurosphere system to assess proliferation
and differentiation, E16.5 neurospheres were assayed for
possible variations in size, number, BrdU incorporation,
and capacity for multi-lineage differentiation after plating
on laminin- and poly-D-lysine-coated coverslips. Cell
marker analysis was also performed. E16.5 HMGB2-/-
neurospheres were smaller than WT E16.5 neurospheres
(Figure 4A,D). Counterstaining with Hoechst allowed for
visualization of the nuclei, revealing that neurospheres
of similar sizes contained comparable numbers of cells.
When proliferation was assessed using BrdU incorpor-
ation (Figure 4B,D), differences were observed only in the
smaller neurospheres: higher numbers of BrdU+ cells
were observed in the HMGB2-/- neurospheres with diam-
eter less than 50 μm. Apoptotic cell death, as visualized by
immunofluorescent staining for activated caspase 3, was
similar between the two genotypes in all neurospheres.
Moreover, differentiation conditions did not result in al-
tered proportions of astrocyte (GFAP+ cells), neuronalFigure 4 Embryonic HMGB2-/- neurospheres differentiate similarly to
neurosphere sizes (A) in E16.5 HMGB2-/- neurospheres compared to WT E1
activated caspase 3+ cells/sphere. (D) BrdU+ labeled spheres from HMGB2
neurospheres give rise to GFAP+, βIII tubulin+, and CNP+ cells. N=4 biolog
replicate. Scale bar: 20 μm. * indicates that p≤0.05.(βIII tubulin+), or oligodendrocyte (CNP+) cell popula-
tions (Figure 4E-F).
Discussion
In an effort to determine markers that affect NSC main-
tenance, quantitative shotgun proteomic analysis of proli-
ferating E12.5 NSCs was used to identify 383 proteins of
which a select number were validated by quantitative
immunoblot analysis. We focused on the chromatin struc-
tural proteins of the HMGB family and confirmed that
HMGB1, 2, 3, and 4 were present in proliferating NSCs
both at the mRNA and protein levels. Although HMGB1,
2, and 3 mRNA expression changed over time in prolifer-
ating NSCs, the HMGB1, 2, and 3 protein expression was
stable (Figures 1, 2, 3). During differentiation HMGBs are
expressed differentially in NSCs, with decreased HMGB1
and 2 mRNA and protein expression 24 hours after initiat-
ing NSC differentiation.
The HMGB1 and B2 expression patterns we report here
parallel the HMGA2 expression pattern in NSCs [11].
HMGA2 expression is higher in the NSC proliferative
compartment of the embryonic telencephalon (ventriclewt ones. Quantitative analysis of the distribution of HMGB2-/-
6.5 neurospheres, (B) numbers of BrdU+ cells/sphere, (C) numbers of
-/- and WT E16.5 mice. (E, F) Differentiation of E16.5 HMGB2-/-
ical replicates for each genotype and 15 neurospheres/biological
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Both HMGB1 and B2 expression is high at early stages
of development (during the proliferative phase) and de-
creases substantially in differentiating NSCs. These ex-
pression patterns suggest possible roles for these proteins
in the proliferation of radial glia in the embryonic mouse
brain, and potentially during repair mechanisms after in-
jury in the adult. Consistent with this idea, findings from
studies on repair mechanisms following intracerebral
hemorrhage suggest a role of HMGB1 in neurogenesis
[37]. Since HMGB2 underwent a more dramatic change
in expression than HMGB1, we focused our attention on
it. In agreement with our findings, Taniguchi et al report
in human mesenchymal stem cells that HMGB2 expres-
sion was high in proliferating cells and decreased as the
cells differentiated [38].
An intriguing finding of our data is the decrease in
HMGB2 mRNA levels in proliferating NSCs between E12
and E15.5 (Figure 2A) while the protein expression level
remained stable (Figure 2C), presumably due to the long
half-lives that the HMGB proteins are reported to have
(~65 hours). The results suggest that there may be ne-
gative regulation of HMGB2 mRNA expression in proli-
ferating NSCs during neural development. MicroRNA(s)
have been shown to regulate expression of genes in neural
progenitors in the adult SVZ neurogenic cascade [39-41],
so it is possible that they modulate HMGB2 expression as
well. Using MicroCosym Targets Version 5 and miRBase
(Enright Lab, European Bioinformatics Lab), an analytic
tool which applies the miRanda algorithm to search
for putative microRNA binding sites in target mRNAs
[42,43], we found putative miRNA binding sites in the
HMGB1 mRNA and 45 different miRNA binding sites in
HMGB2. Among them were several binding sites for
members of the Let-7 family of microRNAs, including
Let-7a,f,g and Let7-b, which have been reported to ne-
gatively regulate HMGA2 in NSCs [11]. Several miRNAs
have been reported to regulate the expression of members
of the HMGB family in different systems [44-46], however
it remains unclear what role microRNAs have in the re-
gulation of HMGB1 or B2 expression in the embryonic
neurogenic niche.
HMGB2 deficiency resulted in neurospheres of smaller
overall size than that observed for wild-type neurospheres
(Figure 4), a change that was accompanied by increased
proliferation. It is conceivable that the significant increase
in small spheres (<50 μm) in absence of HMGB2, along
with the increased BrdU incorporation within those
clones, is indicative of greater numbers of symmetric di-
visions [47] of the NSCs. This result suggests that a phy-
siological role for HMGB2 is the possible suppression of
proliferation and growth by modifying chromatin struc-
ture in NSCs. Consistent with this idea, using a heart
failure model that results in heart hypertrophy andincreased proliferation of cardiomyocytes, Franklin et al.
reported that HMGB2 attenuates pathologic cell growth
and regulates the expression of genes that are responsible
for hypertrophic cell growth. This property was not shared
by HMGB1 [48]. It is possible, therefore, that the decrease
of HMGB2 expression in the NSCs during embryonic
development allows for proliferation and growth of the
neural stem cell population.
Conclusion
In conclusion, we report here that HMGB chromatin
structural proteins are differentially expressed in prolif-
erating and differentiating NSCs, suggesting the possibil-
ity that HMGBs play a regulatory role in NSC processes.
Although HMGB2 knockout mice were previously gen-
erated, characterized, and found to exhibit defects in
spermatogenesis [35] and chondrocyte development and
differentiation [49], neurogenesis in the mice has not
been addressed. Currently, we are investigating the role
of HMGB2 in proliferation, survival, and differentiation
of embryonic and adult NSCs.
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